News
Sudden federal takeovers of America’s cities will apparently be the new normal under the Trump administration. Several ...
Early bedtimes can slip through the cracks over the summer as kids stay up for sleepovers, movie marathons and long plane ...
The Clean Label Project tested store-bought coffee and found it is mostly free of harmful levels of toxins and contaminants, ...
The U.S. Food and Drug Administration has approved Insmed's daily bronchiectasis pill, brensocatib, which will be sold under ...
The FDA’s top vaccine regulator is returning to his post less than 2 weeks after the White House had him ousted.
Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues
CBER Chief Vinay Prasad reclaimed his job less than two weeks after his mysterious exit; MAHA implementor Gray Delany is out ...
DermaRite Industries is recalling certain lots of its over-the-counter soaps, antiseptics, and analgesics due to ...
A reusable product can help save money over the long term. Celikoyar estimates that she was using three tampons every day for ...
A Food and Drug Administration official is getting his job back as the agency’s top vaccine regulator, less than two weeks ...
In our Venable FDA Pulse series, we report on critical developments within the Food and Drug Administration (FDA or the Agency) that may affect ...
CDC shooting tied to anti-vaccine beliefs sparks warnings from staff, as leaders clash over the future of mRNA vaccines and ...
1d
Pharmaceutical Technology on MSNPrasad’s shock FDA return reignites regulatory uncertainty
Vinay Prasad resumes leadership at the FDA’s CBER two weeks after he resigned amid cell and gene therapy controversy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results